doi: 10.1016/0166-3542(91)90013-h.
Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT) and recombinant alpha interferon
Affiliations
- PMID: 1683214
- DOI: 10.1016/0166-3542(91)90013-h
Item in Clipboard
Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT) and recombinant alpha interferon
Antiviral Res.
1991 May.
Abstract
1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) has recently proved to be a potent and selective inhibitor of human immunodeficiency virus type 1 (HIV-1) in vitro. Combinations of HEPT and recombinant alpha interferon (IFN-alpha) synergistically inhibit the replication of HIV-1 in MT-4 cells at non-toxic concentrations. Synergistic inhibition of HIV-1 replication has also been observed in peripheral blood lymphocytes. These results indicate that the combination of HEPT with IFN-alpha should be further pursued in the treatment of retrovirus infections [i.e. acquired immune deficiency syndrome (AIDS)].
Similar articles
-
Anti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivatives.Antimicrob Agents Chemother. 1990 Dec;34(12):2358-63. doi: 10.1128/AAC.34.12.2358. Antimicrob Agents Chemother. 1990. PMID: 2088190 Free PMC article.
-
Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.Biochem Biophys Res Commun. 1989 Dec 29;165(3):1375-81. doi: 10.1016/0006-291x(89)92756-3. Biochem Biophys Res Commun. 1989. PMID: 2575380
-
Effect of human serum on the in vitro anti-HIV-1 activity of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) derivatives as related to their lipophilicity and serum protein binding.Biochem Pharmacol. 1993 Jun 22;45(12):2507-12. doi: 10.1016/0006-2952(93)90232-l. Biochem Pharmacol. 1993. PMID: 8328988
-
Comparative QSAR based on neural networks for the anti-HIV activity of HEPT derivatives.Curr Pharm Des. 2003;9(22):1817-26. doi: 10.2174/1381612033454423. Curr Pharm Des. 2003. PMID: 12871199 Review.
-
Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase.J Enzyme Inhib Med Chem. 2006 Aug;21(4):329-50. doi: 10.1080/14756360600774413. J Enzyme Inhib Med Chem. 2006. PMID: 17059165 Review.
Cited by
-
Combinative interactions of a human immunodeficiency virus (HIV) Tat antagonist with HIV reverse transcriptase inhibitors and an HIV protease inhibitor.Antimicrob Agents Chemother. 1994 Feb;38(2):348-52. doi: 10.1128/AAC.38.2.348. Antimicrob Agents Chemother. 1994. PMID: 7514858 Free PMC article.
-
Antiviral therapy for human immunodeficiency virus infections.Clin Microbiol Rev. 1995 Apr;8(2):200-39. doi: 10.1128/CMR.8.2.200. Clin Microbiol Rev. 1995. PMID: 7542558 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
